SE461040B - Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav - Google Patents

Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav

Info

Publication number
SE461040B
SE461040B SE8301725A SE8301725A SE461040B SE 461040 B SE461040 B SE 461040B SE 8301725 A SE8301725 A SE 8301725A SE 8301725 A SE8301725 A SE 8301725A SE 461040 B SE461040 B SE 461040B
Authority
SE
Sweden
Prior art keywords
thiadiazole
amino
propylamino
methyl
formula
Prior art date
Application number
SE8301725A
Other languages
English (en)
Swedish (sv)
Other versions
SE8301725D0 (sv
SE8301725L (sv
Inventor
R R Crenshaw
A A Algieri
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8301725D0 publication Critical patent/SE8301725D0/xx
Publication of SE8301725L publication Critical patent/SE8301725L/xx
Publication of SE461040B publication Critical patent/SE461040B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/06—1,2,3-Thiadiazoles; Hydrogenated 1,2,3-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8301725A 1982-03-29 1983-03-28 Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav SE461040B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36320782A 1982-03-29 1982-03-29

Publications (3)

Publication Number Publication Date
SE8301725D0 SE8301725D0 (sv) 1983-03-28
SE8301725L SE8301725L (sv) 1983-11-25
SE461040B true SE461040B (sv) 1989-12-18

Family

ID=23429274

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8301725A SE461040B (sv) 1982-03-29 1983-03-28 Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav
SE8704689A SE464302B (sv) 1982-03-29 1987-11-25 Etandiimidamider som mellanprodukter foer framstaellning av histamin -h2-receptorantagonister och foerfarande foer framstaellning daerav

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8704689A SE464302B (sv) 1982-03-29 1987-11-25 Etandiimidamider som mellanprodukter foer framstaellning av histamin -h2-receptorantagonister och foerfarande foer framstaellning daerav

Country Status (30)

Country Link
JP (2) JPS58180477A (de)
KR (1) KR880002209B1 (de)
AT (1) AT386599B (de)
AU (2) AU557577B2 (de)
BE (1) BE896291A (de)
CH (2) CH660880A5 (de)
CS (2) CS250229B2 (de)
DD (2) DD219768A5 (de)
DE (1) DE3311281A1 (de)
DK (2) DK166677B1 (de)
ES (3) ES8404683A1 (de)
FR (2) FR2542741B1 (de)
GB (2) GB2117769B (de)
GR (1) GR78524B (de)
HU (2) HU196386B (de)
IE (1) IE55596B1 (de)
IL (1) IL68259A0 (de)
IT (1) IT1164633B (de)
LU (1) LU84716A1 (de)
MY (1) MY8700942A (de)
NL (1) NL8301063A (de)
NO (1) NO163055C (de)
NZ (1) NZ203726A (de)
OA (1) OA07356A (de)
PT (1) PT76459B (de)
SE (2) SE461040B (de)
SU (2) SU1419518A3 (de)
YU (1) YU44849B (de)
ZA (1) ZA832154B (de)
ZW (1) ZW7683A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4593039A (en) * 1984-04-02 1986-06-03 Merck & Co., Inc. 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols
US4644006A (en) * 1984-06-22 1987-02-17 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
JPH0622828B2 (ja) * 1986-06-30 1994-03-30 フアナツク株式会社 直圧式型締機構
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3018289A (en) * 1960-02-10 1962-01-23 Wyandotte Chemicals Corp Process for preparing oxamidines
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
DK160611C (da) * 1979-09-04 1991-09-16 Bristol Myers Squibb Co Analogifremgangsmaade til fremstilling af 3,4-disubstituerede 1,2,5-thiadiazol-1-oxider og -1,1-dioxider
DE3175201D1 (en) * 1980-04-30 1986-10-02 Merck & Co Inc Aminothiadiazoles as gastric secretion inhibitors
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives

Also Published As

Publication number Publication date
DD210909A5 (de) 1984-06-27
JPS58180477A (ja) 1983-10-21
ES8505978A1 (es) 1985-06-16
DK81192A (da) 1992-06-18
ES8505977A1 (es) 1985-06-16
NO163055C (no) 1990-03-28
NZ203726A (en) 1986-05-09
GR78524B (de) 1984-09-27
GB2117769B (en) 1985-08-29
IE830686L (en) 1983-09-29
YU74483A (en) 1986-02-28
ES520982A0 (es) 1984-05-16
LU84716A1 (fr) 1983-12-05
KR840004095A (ko) 1984-10-06
SE8301725D0 (sv) 1983-03-28
ZA832154B (en) 1983-12-28
GB8308518D0 (en) 1983-05-05
SE8301725L (sv) 1983-11-25
SE8704689L (sv) 1987-11-25
PT76459A (en) 1983-04-01
OA07356A (fr) 1984-08-31
HU196386B (en) 1988-11-28
SE464302B (sv) 1991-04-08
DK141383D0 (da) 1983-03-28
AT386599B (de) 1988-09-12
BE896291A (fr) 1983-09-28
IT8348005A0 (it) 1983-03-28
CH655111A5 (de) 1986-03-27
SU1355123A3 (ru) 1987-11-23
JPH0568472B2 (de) 1993-09-29
CH660880A5 (de) 1987-05-29
HU188742B (en) 1986-05-28
SU1419518A3 (ru) 1988-08-23
IT1164633B (it) 1987-04-15
DE3311281A1 (de) 1983-11-24
ATA111083A (de) 1988-02-15
ZW7683A1 (en) 1984-01-04
KR880002209B1 (ko) 1988-10-18
DK81192D0 (da) 1992-06-18
AU6327286A (en) 1987-01-08
FR2597867A1 (fr) 1987-10-30
PT76459B (en) 1986-03-11
GB2117769A (en) 1983-10-19
FR2597867B1 (fr) 1989-12-08
ES527685A0 (es) 1985-06-16
AU557577B2 (en) 1986-12-24
AU1290783A (en) 1983-10-06
YU44849B (en) 1991-04-30
NO831100L (no) 1983-09-30
MY8700942A (en) 1987-12-31
GB2149406A (en) 1985-06-12
FR2542741A1 (fr) 1984-09-21
IE55596B1 (en) 1990-11-21
FR2542741B1 (fr) 1989-12-08
AU586037B2 (en) 1989-06-29
GB8432809D0 (en) 1985-02-06
ES527686A0 (es) 1985-06-16
ES8404683A1 (es) 1984-05-16
NO163055B (no) 1989-12-18
CS250229B2 (en) 1987-04-16
SE8704689D0 (sv) 1987-11-25
CS250240B2 (en) 1987-04-16
DK166677B1 (da) 1993-06-28
DD219768A5 (de) 1985-03-13
DK141383A (da) 1983-09-30
JPH06135925A (ja) 1994-05-17
IL68259A0 (en) 1983-06-15
GB2149406B (en) 1986-01-02
NL8301063A (nl) 1983-10-17

Similar Documents

Publication Publication Date Title
KR880000968B1 (ko) 1, 2-디아미노 시클로부텐-3, 4-디온 및 그의 제조방법
EP0279681A3 (de) Gesättigte heterocyclische Carboxamidderivate
AU2010261791B2 (en) Anthelmintic agents and their use
UA74579C2 (en) Derivatives of arylmethylamine for use as tryptase inhibitors, a pharmaceutical composition based thereon (variants)
CA2075673A1 (en) (2-alkyl-3-pyridyl)methylpiperazine derivatives
US4440933A (en) Process for preparing 1,2,5-thiadiazoles
CH666033A5 (de) 1,4-dihydropyridinderivate und deren salze und hydrate, verfahren zur herstellung dieser verbindungen und solche verbindungen enthaltende pharmazeutische praeparate.
SE461040B (sv) Substituerade 3,4-diamino-1,2,5-tiadiazoler samt foerfarande foer framstaellning daerav
JPH0352877A (ja) アミノアルキル置換２―アミノチアゾール―誘導体
US4528375A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528378A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4600779A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4528377A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
US4588826A (en) Ethanediimidamide intermediates
US4578471A (en) Substituted amino alkyl pyridyl ethanediimidamides
JP3061631B2 (ja) 新規なヘテロ環化合物およびその製造法
US4517366A (en) Intermediates for preparing 3,4-diamino-1,2,5-thiadiazoles
US4595758A (en) Ethanediimidamide intermediates
KR880002530B1 (ko) 치환된 에탄디이미드 아미드 및 그의 제조방법
DE69302515T2 (de) Antimagengeschwür Pyridyloxyderivate, Verfahren zu deren Herstellung und ihre Verwendung
CA1253144A (en) Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h.sub.2-receptor antagonist activity
NO880872L (no) Fremgangsmaate til fremstilling av en kjemisk forbindelse.
NO157576B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tioalkylamid av nikotinsyre-1-oksyd.
CS246052B2 (en) Method of 3,4-disubstituted 1,2,5-thiadiazole-1-oxides and-1,1-dioxides production
SE447112B (sv) Mellanprodukter for framstellning av 4-hydroxi-3-(5-metyl-3-isoxazolylkarbamoyl)-2-metyl-2h-1,2-bensotiazin-1,1-dioxid med anti-inflammatorisk aktivitet

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8301725-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8301725-1

Format of ref document f/p: F